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Following a long tradition of 
demonizing those who look different, 
a surprising number of Hollywood 
movies cast serial killers, mass 
murderers, and assassins as albinos who 
invariably wind up meeting a gruesome 
end for their menacing ways. The 
cold-blooded sharpshooter portrayal 
is especially ludicrous, points out 
dermatologist Vail Reese (on http://
www.skinema.com), given that vision 
problems routinely arise with this rare 
genetic condition.
Albinism, once classified based on 
appearance, is defined by the genetic 
mutations that determine the degree 
to which all pigmented tissues (skin, 
hair, and eyes) (ocular-cutaneous 
albinism, or OCA) or just the optic 
tissues (ocular albinism, or OA) are 
affected. One gene, Oa1, has been 
linked to OA, and several mutations 
have been associated with OCA. The 
OCA mutations inhibit different 
components involved in the synthesis 
of melanin, the photoprotective 
pigment in the skin that absorbs 
harmful ultraviolet rays, and invariably 
impair vision. Paradoxically, the 
mutated pigmentation genes are not 
expressed in the retina but in adjacent 
retinal pigment epithelial (RPE) cells, 
suggesting that pigment loss in RPE 
cells disturbs retinal development. 
In a new study from the McKay 
laboratory, Vanessa Lopez et al. 
studied the relationship between cells 
in the retina and those in RPE cells 
by investigating the function of Oa1,
thought to belong to one of the largest 
and important protein superfamilies, 
called G-protein coupled receptors 
(GPCRs). These receptors mediate 
cellular responses to environmental 
signals and play a critical role in a wide 
range of processes, from embryonic 
development to metabolism, by binding 
to molecules (called ligands) that 
trigger signaling cascades within the 
cell. Lopez et al. sought to identify 
the ligand for this putative GCPR to 
understand how defects in melanin 
synthesis and retinal development 
might occur in tandem.
In experiments designed to 
determine OA1 localization in human 
eye tissue, the researchers found a 
significant fraction of the protein on 
the RPE apical surface, which interacts 
with photoreceptors in the retina. 
Previous efforts to locate OA1 yielded 
conflicting results, with some groups 
finding modified versions of the 
receptor primarily in endosomes (in 
cultured cells) and others detecting it 
at the cell surface after overexpressing 
OA1 or inhibiting endocytosis. Since 
receptors are typically internalized 
(through endocytosis) within 
endosomes after they’ve been 
stimulated by a ligand, the researchers 
tried to find a potential ligand in 
cultured cells. And since the amino 
acid used to synthesize melanin 
(tyrosine) is a standard component 
of cell culture medium, tyrosine 
seemed a likely trigger for OA1 
internalization.
In a medium with little or no 
tyrosine, OA1 appeared on the surface 
of RPE cells, much as it had in the 
eye tissue. In contrast, when using 
standard medium, the researchers 
could not consistently detect OA1 on 
the surface of the cells, suggesting 
that tyrosine had indeed induced OA1 
internalization, consistent with ligand 
binding. But was the ligand tyrosine or 
something else?
During melanin synthesis, enzymes 
act on tyrosine to yield L-DOPA, 
which begets another intermediate 
that ultimately produces the pigment. 
(L-DOPA is also a precursor of 
dopamine, an important signaling 
molecule in the brain.) If tyrosine 
or its metabolites could trigger OA1 
signaling, the researchers reasoned, 
they should see a release of calcium 
inside the cell, as normally occurs 
when a ligand stimulates a GPCR. 
Although neither tyrosine nor 
dopamine increased calcium levels 
inside the cell, L-DOPA triggered a 
significant release of intracellular 
calcium. The same thing happened 
when the researchers exposed RPE 
cells to L-DOPA. As expected if 
L-DOPA was an OA1 ligand, most of 
the receptors were shown to be bound 
by this tyrosine metabolite.  
doi:10.1371/journal.pbio.0060248.g001
An autocrine loop between OA1 and tyrosinase and linked through L-DOPA includes the 
secretion of at least one very potent retinal neurotrophic factor, PEDF. Changes in OA1 
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Since OA1 mutations cause both 
retinal defects and pigment loss in 
RPE, and pigmented RPE produces far 
more of a molecule that is important 
for normal retinal development (called 
pigment epithelium-derived factor, or 
PEDF) than nonpigmented RPE does, 
the researchers wondered whether 
L-DOPA could increase PEDF levels. 
Sure enough, exposing RPE cells to 
L-DOPA led to a significant increase in 
PEDF expression. This increase, they 
show, requires the action of the enzyme 
that converts tyrosine to L-DOPA, which 
in turn triggers OA1 signaling.
Based on these results, the 
researchers conclude that tyrosine, 
L-DOPA, and OA1 interact to 
regulate PEDF and that changes 
in OA1 signaling may underlie the 
disruptions in retinal development 
that cause albinism-related vision 
problems. Future studies can gain 
a more detailed understanding of 
the L-DOPA–OA1 signaling pathway 
by identifying molecules that may 
inhibit the ligand through competitive 
binding with the OA1 receptor. 
Researchers can also investigate 
pharmacological strategies that 
could compensate for disrupted OA1 
signaling in individuals with albinism 
by repairing defects in the melanin 
pathway. But such strategies may prove 
difficult, the researchers caution. 
Their results suggest that the OA1 
receptor appears necessary to support 
such drugs—and mutations in the Oa1 
gene are the most common cause of 
albinism.
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